Is LYOCONTRACT GmbH FDA approved?

LYOCONTRACT GmbH holds 1 FDA-registered establishment in Germany. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are LYOCONTRACT GmbH's drugs manufactured?

The FDA register lists Ilsenburg. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, sterilize.

What drugs does LYOCONTRACT GmbH make?

6 products are listed under LYOCONTRACT GmbH in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; powder, for solution; for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

LYOCONTRACT GmbH

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 6
Live patents: 0
Countries: 1
Base: Germany

Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1sterilize1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
LYOCONTRACT GmbH	Pulverwiese 1, Ilsenburg, 38871, Germany (DEU)	Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize	3014034890340921746

Catalogue

Drug listings by form and route

6 active NDC listings: 6 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 6.

Dosage form	NDCs
injection, powder, lyophilized, for solution	3
powder, for solution	2
for solution	1

Route	NDCs

Labeller name on the listing	NDCs
lyocontract gmbh	6

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	INCOBOTULINUMTOXIN A	injection, powder, lyophilized, for solution	71956-201DRUG FOR FURTHER PROCESSING
-	INCOBOTULINUMTOXIN A	injection, powder, lyophilized, for solution	71956-202DRUG FOR FURTHER PROCESSING
-	INDOCYANINE GREEN	powder, for solution	71956-725DRUG FOR FURTHER PROCESSING
-	INDOCYANINE GREEN	injection, powder, lyophilized, for solution	71956-726DRUG FOR FURTHER PROCESSING
-	LANDIOLOL	powder, for solution	71956-110DRUG FOR FURTHER PROCESSING
-	aminolevulinic acid hydrochloride	for solution	71956-001DRUG FOR FURTHER PROCESSING

Compare

Comparable companies in Germany

Excella GmbH & Co. KG1 site · 73 NDC
PEKANA Naturheilmittel GmbH1 site · 62 NDC
Nestmann Pharma GMBH1 site · 18 NDC
Rottendorf Pharma GmbH1 site · 17 NDC
Eckert & Ziegler Radiopharma GmbH1 site · 11 NDC
Heraeus Precious Metals GmbH Co KG1 site · 10 NDC
Solupharm Pharmazeutische Erzeugnisse GmbH1 site · 10 NDC
CU Chemie Uetikon GmbH1 site · 9 NDC
Thomas Brunner Hygiene GmbH1 site · 8 NDC
Chemcon GmbH1 site · 7 NDC

Enquiry

Common questions

Is LYOCONTRACT GmbH FDA approved?: LYOCONTRACT GmbH holds 1 FDA-registered establishment in Germany. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are LYOCONTRACT GmbH's drugs manufactured?: The FDA register lists Ilsenburg. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, sterilize.
What drugs does LYOCONTRACT GmbH make?: 6 products are listed under LYOCONTRACT GmbH in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; powder, for solution; for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.